Clevergene
PrivateLast Round
Seed
Feb 12, 2020
Total Funding Raised
$631,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Clevergene operates in Healthcare & Life Sciences and is based in Bangalore. Its latest recorded funding round was a Seed round in February 2020.
Clevergene is a biotechnology company that provides integrated genomics services, including next-generation sequencing, bioinformatics, and genetic diagnostics for research and clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clevergene Comparables
Compare Clevergene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SciGenom Labs | 86% | |
| Nucleome Informatics Private Limited | 86% | |
| Genotypic Technology | 83% |
For institutional investors. Book with your work email.
Clevergene Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Clevergene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Auxano Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 89% MoM to 2.1K.
- Jun 8, 2025
Grew 19% QoQ, from 16 to 19 employees.
For institutional investors. Book with your work email.
Clevergene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Clevergene's valuation, stock price, and market status.
Is Clevergene a public or private company?
Clevergene is a private company.
What is the current stock price of Clevergene?
Clevergene is a private company, so its shares have no public market price. Caplight tracks Clevergene's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Clevergene worth (valuation)?
Valuation information for Clevergene is not publicly available.
Can I buy Clevergene stock?
Clevergene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Clevergene's last funding round?
Clevergene's most recent funding round was Seed on February 12, 2020.
Who are the main investors in Clevergene?
Key investors in Clevergene include Auxano Capital.
Will Clevergene IPO soon?
No public IPO plans have been announced for Clevergene.
How can I track Clevergene secondary market activity?
Caplight tracks bids, offers, and trades in Clevergene's shares on secondary markets.